DK3177279T3 - Oral sammensætning til indgivelse af medikamenter og andre substanser - Google Patents
Oral sammensætning til indgivelse af medikamenter og andre substanserInfo
- Publication number
- DK3177279T3 DK3177279T3 DK15832041.6T DK15832041T DK3177279T3 DK 3177279 T3 DK3177279 T3 DK 3177279T3 DK 15832041 T DK15832041 T DK 15832041T DK 3177279 T3 DK3177279 T3 DK 3177279T3
- Authority
- DK
- Denmark
- Prior art keywords
- medications
- administration
- substances
- oral composition
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462035393P | 2014-08-09 | 2014-08-09 | |
| PCT/US2015/044501 WO2016025401A1 (en) | 2014-08-09 | 2015-08-10 | Oral composition for delivery of drugs and other substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3177279T3 true DK3177279T3 (da) | 2025-08-18 |
Family
ID=55304531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15832041.6T DK3177279T3 (da) | 2014-08-09 | 2015-08-10 | Oral sammensætning til indgivelse af medikamenter og andre substanser |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9872908B2 (enExample) |
| EP (1) | EP3177279B1 (enExample) |
| JP (1) | JP6759203B2 (enExample) |
| KR (2) | KR102507657B1 (enExample) |
| CN (1) | CN107072967B (enExample) |
| AU (1) | AU2015301952B2 (enExample) |
| CA (1) | CA2956960C (enExample) |
| DK (1) | DK3177279T3 (enExample) |
| ES (1) | ES3033965T3 (enExample) |
| IL (1) | IL250394B (enExample) |
| WO (1) | WO2016025401A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015301952B2 (en) * | 2014-08-09 | 2020-12-03 | Avanti Polar Lipids, Inc. | Oral composition for delivery of drugs and other substances |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2514755A1 (fr) | 1981-10-21 | 1983-04-22 | Rhone Poulenc Chim Base | Procede de preparation de l'anhydride acetique |
| ZA831053B (en) * | 1982-02-17 | 1985-03-27 | Ciba Geigy Ag | Lipids in aqueous phase |
| DE3374837D1 (en) * | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| EP0102324A3 (de) * | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| IE59067B1 (en) * | 1985-04-02 | 1993-12-15 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| JPH01274830A (ja) * | 1988-04-28 | 1989-11-02 | Asahi Denka Kogyo Kk | 安全で且つ高度な界面活性を有する脂質組成物 |
| JPH03127731A (ja) * | 1989-10-12 | 1991-05-30 | Yakult Honsha Co Ltd | ビタミンｅの可溶化方法およびビタミンｅ製剤 |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| EP2062574B1 (en) * | 2006-09-08 | 2015-03-25 | Kaneka Corporation | Composition comprising reduced coenzyme q10 and lysolecithin |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| AU2015301952B2 (en) * | 2014-08-09 | 2020-12-03 | Avanti Polar Lipids, Inc. | Oral composition for delivery of drugs and other substances |
-
2015
- 2015-08-10 AU AU2015301952A patent/AU2015301952B2/en active Active
- 2015-08-10 WO PCT/US2015/044501 patent/WO2016025401A1/en not_active Ceased
- 2015-08-10 KR KR1020227016492A patent/KR102507657B1/ko active Active
- 2015-08-10 EP EP15832041.6A patent/EP3177279B1/en active Active
- 2015-08-10 CN CN201580049486.0A patent/CN107072967B/zh active Active
- 2015-08-10 US US14/822,289 patent/US9872908B2/en active Active
- 2015-08-10 ES ES15832041T patent/ES3033965T3/es active Active
- 2015-08-10 JP JP2017527546A patent/JP6759203B2/ja active Active
- 2015-08-10 DK DK15832041.6T patent/DK3177279T3/da active
- 2015-08-10 KR KR1020177006233A patent/KR20170033442A/ko not_active Ceased
- 2015-08-10 CA CA2956960A patent/CA2956960C/en active Active
-
2017
- 2017-02-01 IL IL250394A patent/IL250394B/en active IP Right Grant
- 2017-11-08 US US15/807,389 patent/US10463738B2/en active Active
-
2019
- 2019-10-31 US US16/669,825 patent/US11510985B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102507657B1 (ko) | 2023-03-08 |
| KR20220070551A (ko) | 2022-05-31 |
| IL250394A0 (en) | 2017-03-30 |
| IL250394B (en) | 2021-05-31 |
| KR20170033442A (ko) | 2017-03-24 |
| AU2015301952B2 (en) | 2020-12-03 |
| CA2956960C (en) | 2023-10-24 |
| EP3177279B1 (en) | 2025-06-04 |
| CN107072967B (zh) | 2021-01-12 |
| WO2016025401A1 (en) | 2016-02-18 |
| US9872908B2 (en) | 2018-01-23 |
| CN107072967A (zh) | 2017-08-18 |
| US11510985B2 (en) | 2022-11-29 |
| AU2015301952A1 (en) | 2017-02-16 |
| EP3177279A1 (en) | 2017-06-14 |
| ES3033965T3 (en) | 2025-08-11 |
| JP6759203B2 (ja) | 2020-09-23 |
| CA2956960A1 (en) | 2016-02-18 |
| JP2017524036A (ja) | 2017-08-24 |
| US20180064813A1 (en) | 2018-03-08 |
| EP3177279A4 (en) | 2018-04-18 |
| US20200188518A1 (en) | 2020-06-18 |
| US20160166699A1 (en) | 2016-06-16 |
| US10463738B2 (en) | 2019-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3506884T4 (da) | Sammensætninger til indgivelse af medicin og anvendelser deraf | |
| DK3212230T3 (da) | Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3302638T3 (da) | Anordning til indgivelse af lægemidler | |
| DK3153169T3 (da) | Fremgangsmåde til behandling af tumor, farmaceutisk sammensætning og medicinæskesæt | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| HUE047784T2 (hu) | Anti-TIM3 antitestek és alkalmazási eljárások | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3218828T3 (da) | Dataindsamling til dosering af lægemidler | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK4335517T3 (da) | Indgivelse og dosering af diaminofenothiaziner | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3821905T3 (da) | Insulin indeholdende farmaceutiske sammensætninger | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3160521T3 (da) | Prøvetagningsanordning til bestemmelse af mængde og indgivet lægemiddeldosis og tilhørende fremgangsmåder | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| DK2956149T3 (da) | Farmaceutiske sammensætninger til behandling af helicobacter pylori | |
| DK3236934T3 (da) | Farmaceutisk sammensætning, fremstilling og anvendelser deraf | |
| DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
| DK3328368T3 (da) | Forbindelser og farmaceutisk sammensætning associeret med ubiquitinering-proteasomsystem |